Cancer Copilot

by Color Health  · Based in United States → — AI for Cancer Care: Changing care by expanding expertise
Hematology Oncology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Overview

Color Health’s Cancer Copilot, built with OpenAI, is an AI tool designed to assist oncologists and other clinicians in identifying and ordering necessary workups for recently diagnosed cancer patients. The goal is to accelerate the time to cancer treatment, which is critically important as delays can increase mortality risk. The tool combines large language models (LLMs) with knowledge bases built on cancer guidelines and a user-friendly interface. It aims to reduce clinical tasks that typically take two hours down to approximately ten minutes, with a validated accuracy of over 95%. Clinicians remain central to all decision-making, with AI serving to scale their ability to serve more patients, broaden their expertise, and consider holistic patient needs. Color Health also offers a Virtual Cancer Clinic, which is ASCO Certified and provides comprehensive cancer care from screening and diagnosis through treatment and survivorship.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered identification and ordering of workup needs for cancer patients
  • Integration of large language models (LLMs) with cancer guidelines
  • Reduction of clinical task time from 2 hours to 10 minutes
  • Over 95% validated accuracy in diagnostic recommendations
  • Clinician-in-the-loop design for oversight and decision-making
  • Transparent logic for AI-driven decisions
  • Support for guideline-based cancer care
  • Virtual Cancer Clinic offering end-to-end cancer care
  • Genetic testing for hereditary cancer risk
  • Partnerships with major cancer institutions and research programs

Use Cases

  • Accelerating time to cancer treatment for recently diagnosed patients
  • Assisting oncologists and clinicians with workup identification and ordering
  • Expanding cancer expertise and speeding clinical decisions
  • Improving adherence to cancer screening guidelines
  • Providing virtual, oncologist-led care across the cancer journey
  • Supporting employers, health plans, unions, and public sector organizations in delivering cancer care benefits

Details

Category Oncology AI
Pricing Unknown
  • Color Health primarily serves employers, consultants, health plans, unions, and the public sector, suggesting a B2B pricing model rather than individual patient pricing
DeploymentCloud-based
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Unknown AI-estimated

While Color Health's laboratory is CLIA-certified and CAP-accredited, and the company states it complies with applicable federal and state laws including HIPAA, there is no explicit mention of FDA clearance for the Cancer Copilot AI tool.
Integrations
EHR Not specified
Specialties Hematology, Oncology, Radiology

What the Web Says

Cancer Copilot, developed by Color Health in collaboration with OpenAI, is an AI-powered tool designed to assist clinicians in accelerating and improving cancer care. It leverages large language models (LLMs) like GPT-4o to analyze patient medical data, identify missing diagnostics, and create tailored workup and treatment plans. The tool aims to reduce the time to treatment, increase adherence to screening guidelines, and lower healthcare costs by enabling earlier detection and more efficient care pathways.

Overall: Positive

Strengths

  • Identifies 4x more missing labs, imaging, or biopsy and pathology results, reducing diagnostic delays from weeks to minutes.
  • Reduces the time from abnormal screening to treatment initiation by 66%.
  • Increases adherence to cancer screening guidelines by 77%.
  • Provides proactive ongoing multidisciplinary review for 100% of cancer cases.
  • Helps clinicians create customized, comprehensive treatment plans and supports evidence-based decision-making.
  • Offers a virtual clinic model that expands access to expertise and supports better clinical decisions.

Limitations

  • Some general AI tools, including other Copilot versions, have been noted to produce verbose notes, struggle with chronological organization of medical interviews, and occasionally hallucinate minor details.
  • Concerns exist about the accuracy and reliability of AI outputs, emphasizing the critical need for clinician oversight.
  • A learning curve may be involved in optimizing prompts and tailoring AI outputs effectively.
  • Some users of general AI copilots have reported technical glitches and difficulty connecting to or retrieving health records.
  • The subscription costs for some AI tools can be high, and licensing structures may be complex.

Based on reviews from: OpenAI, PR Newswire, Color Health, Wikipedia, Renee's Ramblings, ZDNET, CNET, arXiv, YouTube, Hacker News, Reddit, Capterra

Last updated: 2026-09-30

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Cancer Copilot

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Color Health
AI for Cancer Care - Color Health
Color Health's Cancer Copilot, built with OpenAI, uses large language models and cancer guidelines to help oncologists identify and order workup needs for recently diagnosed patients, aiming to speed up treatment initiation. The tool has shown over 95% validated accuracy and can reduce a two-hour clinical task to ten minutes.
2026-01
KeyNews.AI
Using GPT-4o reasoning to transform cancer care - KeyNews.AI
Color Health launched Cancer Copilot, powered by GPT-4o, to identify missing diagnostics and create tailored workup plans for cancer patients. This application is deployed in active healthcare provider workflows, not just a pilot stage, and uses AI reasoning for evidence-based cancer screening decisions.
2024-06
Fierce Healthcare
Color Health builds out virtual cancer clinic, taking aim at employer, health plan market
Color Health is expanding its virtual cancer clinic for employers, unions, and health plans, and has developed a generative AI-powered Cancer Copilot app in partnership with OpenAI. This app leverages GPT-4 to identify missing diagnostics and create personalized care plans for cancer patients.
2024-10
Color Health
Color Health receives Newsweek AI Impact award for u201cAI Healthcare: Best Outcomes, Diagnosticsu201d
Color Health's Cancer Copilot received Newsweek's AI Impact award for u201cAI Healthcare: Best Outcomes, Diagnosticsu201d in January 2026. The AI-based diagnostic tool, implemented with UCSF, achieved over 95% accuracy in diagnostic recommendations and reduced workup time from two hours to ten minutes.
2026-01
Verywell Health
AI 'Cancer Copilot' Can Help Rural Doctors Provide Better, Faster Care
A pilot study by Color Health and UCSF found that an AI 'Cancer Copilot' can help rural doctors provide faster and more personalized cancer care by generating preventive oncology screening and workup plans in 15 minutes, with less than 2% physician intervention needed.
2025-04
KFF Health News
First Edition: June 18, 2024 - KFF Health News
The Wall Street Journal reported on OpenAI's expanded healthcare push with Color Health's Cancer Copilot, which uses OpenAI's GPT-4o model to help doctors create cancer screening and pretreatment plans.
2024-06
Newsweek
AI Impact Awards 2025: How 7 Health Care Winners Measure Impact - Newsweek
Color Health, the largest virtual cancer clinic in the U.S., partnered with OpenAI to develop Cancer Copilot, an AI architecture that provides accurate clinical recommendations. The company measures its AI's impact by tracking time saved by clinicians and its ability to expand access to oncology expertise.
2025-06
arXiv
MedRAG: Enhancing Retrieval-augmented Generation with Knowledge Graph-Elicited Reasoning for Healthcare Copilot - arXiv
This paper discusses 'Healthcare Copilot' as a medical AI assistant designed to provide diagnostic decision support and mentions OpenAI's expansion into healthcare with Color Health's Cancer Copilot. It highlights the importance of accurate diagnoses, treatment plans, and proactive follow-up questions in healthcare AI.
2025-02

Videos

Product demos, reviews, and walkthroughs for Cancer Copilot.

View all on YouTube

Frequently Asked Questions

Cancer Copilot is designed to integrate into clinical workflows by aggregating and organizing relevant patient data from medical records, flagging missing information, and integrating national and local guideline recommendations. Its primary uses include establishing preventive oncology screening and workup plans, generating workup plans rapidly, and assisting oncologists in making evidence-based decisions for cancer screening and treatment.
A significant limitation is ensuring the system has access to all of a patient's medical information, as gaps in data availability can lead to recommendations based on incomplete clinical pictures. There are also concerns about potential over-reliance on AI recommendations, which could reduce a clinician's own diagnostic skills over time, and the risk of AI models misleading diagnoses or treatments due to biases or errors.
Ethical concerns include algorithmic transparency, unclear accountability in AI-guided decisions, data privacy, and patient understanding of AI's role in their care. Compliance requires ensuring robust informed consent models, mitigating algorithmic bias, and establishing clear legal accountability, especially regarding HIPAA for tools that handle Protected Health Information (PHI).
Yes, there are several AI copilots and platforms emerging in healthcare. Examples include Microsoft Dragon Copilot (combining ambient documentation and dictation), Google Gemini (with native Google Workspace integration), and other AI assistants like Innovaccer's Provider Copilot, Docus.ai, and Ada Health, which offer various features for clinical documentation, decision support, and patient engagement.
Specific pricing for 'Cancer Copilot' is not publicly disclosed, but similar AI solutions like Microsoft Dragon Copilot often require a quote and can involve significant costs. For instance, some reseller listings suggest costs of approximately $369 to $830+ per provider per month, with potential one-time setup fees, and pricing can vary based on contract size, EHR integration, and contract terms.
Pilot studies have shown promising results, with one study indicating that a workup plan that typically takes two hours to develop was generated in 15 minutes with less than 2% of recommendations needing physician intervention. However, the accuracy and reliability are highly dependent on the completeness of patient data and the continuous oversight of a human clinician, as AI should be viewed as a support tool rather than a replacement for clinical judgment.

Related Tools

Surgical Reality Viewer
Surgical Reality
Oncology AI
Surgical Reality offers CE- and FDA-certified AI-powered 3D medical imaging and surgical planning software that transforms CT scans into patient-specific 3D models for thoracic surgery, enhancing precision in complex lung procedures.
Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
Synapse Lung Nodule AI
Fujifilm Corporation
Oncology AI
Fujifilm's Synapse Lung Nodule AI is an AI software algorithm for detecting pulmonary nodules on CT imaging, aiming to support early detection and treatment of lung cancer.
On request
RadOncAI
Informai (for RadOncAI product) / Global Network for AI in Radiation Oncology (for RadoncAI.net)
Oncology AI
RadOncAI is an AI solution by Informai designed to optimize and enhance radiation oncology workflows, improving efficiency and accuracy in treatment planning and delivery.
FAITH project (Fatigue Therapy – AI-supported Diagnosis and Therapy of Tumour-associated Fatigue Syndrome)
Fimo Health GmbH (Consortium Leader)
Mental & Behavioral Health AI
The FAITH project is developing an AI-based solution for the diagnosis and therapy of tumor-associated fatigue syndrome in cancer patients. It uses wearable sensors, a smartphone app, and artificial intelligence to provide individualized therapy recommendations and monitor mental health.
AI-based support system for skin cancer diagnostics
German Cancer Research Center (DKFZ)
Clinical Decision Support & Reference
Scientists at the German Cancer Research Center have developed an AI-based support system for skin cancer diagnostics that explains its decisions, increasing doctors' confidence in both the AI and their own diagnoses.

See all Oncology AI tools →

Suggest an Edit → | Last Verified: 2026-09-30 | First Added: 2026-09-30

Investors who backed Cancer Copilot

Funded through the company that built this tool.

Hemant Taneja
Solo Angel AI T3
Palo Alto, United States
<$250k
Hemant Taneja is CEO of General Catalyst and angel-invests at $250k+ checks at seed and Series A across digital health, AI/ML in…
AI/ML in Healthcare Care Delivery / Tech-Enabled Services
Foresite Capital
VC T3
San Francisco, United States
$25M+
Foresite Capital is a healthcare-dedicated multi-stage investment firm with substantial assets under management, investing across drug development, medical devices, diagnostics, and healthcare…
AI/ML in Healthcare Biotech
AI Tool Finder
AI-powered search. Results may not be comprehensive.